RBC raises Rhythm Pharmaceuticals target price to $159 from $155
RYTM•RBC raised its target price for Rhythm Pharmaceuticals to $159 from $155.
Related News
Gain Therapeutics to attend Maxim Growth Summit
GANX•
Akamai to host investor call on third-quarter 2026 results
AKAM•
Beamr expects FY2026 revenue to rise about 50% vs FY2025
BMR•
Werner Enterprises, Inc.: Stifel raises target price to $42 from $40
WERN•
Gogo signs USD 15 million-plus GEO satellite connectivity lease with overseas sovereign customer
GOGO•